Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study

BACKGROUND: Extension of dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome is associated with a reduction in ischemic events but also increased bleeding. The DAPT score identifies individuals likely to derive overall benefit or harm from DAPT extension. We sought to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbel, Yaron, Patel, Ashish D., Goodman, Shaun G., Tan, Mary K., Suskin, Neville, McKelvie, Robert S., Mathew, Andrew L., Ahmed, Firas, Lutchmedial, Sohrab, Dehghani, Payam, Lavoie, Andrea J., Huynh, Thao, Lavi, Shahar, Khan, Razi, Yan, Andrew T., Fordyce, Christopher B., Heffernan, Michael, Jedrzkiewicz, Sean, Madan, Mina, Ahmed, Shaheeda, Barry, Colin, Dery, Jean-Pierre, Bagai, Akshay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712544/
https://www.ncbi.nlm.nih.gov/pubmed/34993458
http://dx.doi.org/10.1016/j.cjco.2021.07.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712544/
https://www.ncbi.nlm.nih.gov/pubmed/34993458
http://dx.doi.org/10.1016/j.cjco.2021.07.013

Ejemplares similares